Newsletter Subject

How to Benefit From the Biotech Surge

From

energyandcapital.com

Email Address

newsletter@energyandcapital.com

Sent On

Sat, Oct 30, 2021 05:21 PM

Email Preheader Text

For your weekend reading, we bring you the week's most popular stories from Energy and Capital and o

For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily… For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily… [Energy and Capital logo] How to Benefit From the Biotech Surge [Keith Kohl Photo] By [Keith Kohl]( Written Oct 30, 2021 For your weekend reading, we bring you the week's most popular stories from [Energy and Capital]( and our sister site, [Wealth Daily](… [$500/Week With Options — Here's How]( Start trading options with zero experience…but can you even trade without risking your own money to start? I've found a shortcut. Here's a way to not spend a penny on options but still trade them. This isn't a gimmick, nor are you simulating trades. You can make actual money trading options without risking a penny. So if you're interested in options but worried about losing money, this is a no-brainer way to start trading options with $0. [Introducing Your New Editor]( Your newest Wealth Daily editor has rubbed elbows with former Chicago Board Options Exchange floor traders, Wall Street hedge fund managers, and International Monetary Fund analysts — and was introduced to little-known but very profitable financial instruments. But he always felt something was lacking… [Trump’s SPAC Deal With Digital World Acquisition Corp. (NASDAQ: DWAC) Will Be a Giant Failure]( Look, you may be the biggest Trump supporter in the world, but that doesn’t change the fact that from a historical perspective, his track record with public companies isn’t so hot... [Bitcoin's Big Fall]( President Biden is reshaping our entire financial system as we speak. And in order for his plan to pan out, Bitcoin needs to fall. Biden's team has already taken its first steps to derail Bitcoin, but for investors who position themselves ahead of Bitcoin's demise, a four-figure windfall is possible. [The Crypto Economy Is Growing]( Mastercard (NYSE: MA) is betting big on the growth of the cryptocurrency market. The company announced a partnership with Bakkt (NYSE: BKKT)... This Device Leads the Driverless Surge Right now, there are 39 million self-driving cars on the road. And by 2030, there will be 71 million driverless vehicles on the road. But without a certain company’s patented device, driverless cars wouldn't even be possible. See, many Fortune 500 companies like General Motors, Caterpillar, and NVIDIA are already using this company’s tech.And very soon, every company in the world will utilize this tech as well. You can scoop up shares for a few bucks right now before it becomes one of the hottest names on Wall Street. [Click here now for the full details.]( [Stop Wasting the Government's Money!]( Right now, there is a bureaucratic gridlock threatening the integrity of our entire medical system. And it's happening in complete silence... [New Superfuel Could Be Powering Your Neighborhood Very Soon]( This new superfuel has the potential to power 95 million homes in America, and it's got nothing to do with natural gas, nuclear, hydrogen, or lithium. Endless clean energy is right at our fingertips, thanks to one powerful metal that can literally store and release energy simultaneously. But the best part is that you could be handed a four-digit gain if you get in right now. [The ONLY Thing Trump and Biden Agree On]( There's a TON of government funding coming to a small corner of the market, and you can get a piece of the pie... [WATCH: Almost Dying on the Chesapeake Made Me a Better Trader]( Like the Chesapeake Bay a few weeks back, the markets are extremely volatile right now. But this simple lesson about stocks will ease your angst. [How to Break the Bank on the COVID Bottleneck](We're about to enter the most unique moment in the history of biotech. See, in order to make it all the way through to market, every single drug must gain FDA approval. And the pandemic created a massive approval delay, with hundreds of new drugs just sitting in the pipeline. But the FDA just announced that it's reopening the pipeline... so now billions of dollars' worth of drugs are about to explode out into the market. Until next time, [Keith Kohl Signature] Keith Kohl [[follow basic]@KeithKohl1 on Twitter]( A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of [Energy & Capital](, as well as the investment director of Angel Publishing's [Energy Investor]( and [Technology and Opportunity](. For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology. Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s [Topline Trader]( advisory newsletter. Browse Our Archives [Trump’s SPAC Deal With Digital World Acquisition Corp. (NASDAQ: DWAC) Will Be a Giant Failure]( [Stop Wasting the Government's Money!]( [WATCH: Almost Dying on the Chesapeake Made Me a Better Trader]( [Solar Investments That Pay Double-Digit Dividends]( [The COVID Bottleneck Worth Billions for These Biotech Stocks]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2021, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------

Marketing emails from energyandcapital.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.